Skip to content

ARKLIN: what changed

BE 0787.351.671NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€27,122
2024 · €20,776+€6,346
Equity
€80,994
2024 · €53,872+€27,122
Cash
€1,091
2024 · €34,999-€33,908
Balance sheet total
€577,623
2024 · €81,803+€495,820

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€545,376

    up €545,376 (+5,793%), from €9,414 to €554,790

    of which Trade receivables: +€554,304

  • Cash -€33,908

    down €33,908 (-96.9%), from €34,999 to €1,091

    mainly Receivables within one year (-€545,376) and Investment in fixed assets (net) (-€1,920)

  • Deferred charges and accrued income -€9,550

    down €9,550 (-98.3%), from €9,717 to €167

  • Tangible fixed assets -€6,098

    down €6,098 (-22.0%), from €27,674 to €21,575

    of which Furniture and vehicles: -€7,865

Equity and liabilities
  • Debts after one year +€462,246

    up €462,246 (+3,347%), from €13,810 to €476,055

    of which Other amounts payable: +€470,000

  • Reserves +€27,122

    up €27,122 (+54.4%), from €49,872 to €76,994

  • Tax, wage and social debts +€6,619

    up €6,619 (+114%), from €5,803 to €12,422

    of which Taxes: +€6,617

Income statement
  • Gross operating margin +€8,057

    up €8,057 (+22.2%), from €36,337 to €44,394

  • Taxes +€1,698

    up €1,698 (+27.7%), from €6,142 to €7,841

  • Other operating charges +€453

    up €453, from €0 to €453

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €20,776
Gross operating margin +€8,057
Depreciation +€109
Other operating charges -€453
Financial income -€3
Financial charges +€333
Taxes -€1,698
Result 2025 €27,122
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€494,584
Investment -€1,920
Financing +€462,595
Cash 2024 €34,999
Net result for the year +€27,122
Depreciation +€8,018
Receivables within one year -€545,376
Deferred charges and accrued income +€9,550
Tax, wage and social debts +€6,619
Smaller working-capital items -€516
Investment in fixed assets (net) -€1,920
Debts after one year +€462,246
Current portion of long-term debt +€350
Cash 2025 €1,091
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €81,803 €577,623 +€495,820 +606%
Fixed assets 21/28 €27,674 €21,575 -€6,098 -22.0%
Tangible fixed assets 22/27 €27,674 €21,575 -€6,098 -22.0%
Plant, machinery and equipment 23 - €1,767 +€1,767
Furniture and vehicles 24 €27,674 €19,808 -€7,865 -28.4%
Current assets 29/58 €54,130 €556,048 +€501,918 +927%
Amounts receivable within one year 40/41 €9,414 €554,790 +€545,376 +5,793%
Trade receivables 40 €486 €554,790 +€554,304 +114,115%
Other amounts receivable 41 €8,928 €0 -€8,928 -100%
Cash at bank and in hand 54/58 €34,999 €1,091 -€33,908 -96.9%
Deferred charges and accrued income 490/1 €9,717 €167 -€9,550 -98.3%
Total equity and liabilities 10/49 €81,803 €577,623 +€495,820 +606%
Equity 10/15 €53,872 €80,994 +€27,122 +50.3%
Contributions 10/11 €4,000 €4,000 = 0.0%
Reserves 13 €49,872 €76,994 +€27,122 +54.4%
Distributable reserves 133 €49,872 €76,994 +€27,122 +54.4%
Amounts payable 17/49 €27,931 €496,629 +€468,698 +1,678%
Amounts payable after more than one year 17 €13,810 €476,055 +€462,246 +3,347%
Financial debts 170/4 €13,810 €6,055 -€7,755 -56.2%
Other amounts payable 178/9 - €470,000 +€470,000
Amounts payable within one year 42/48 €13,208 €20,472 +€7,264 +55.0%
Current portion of amounts payable after more than one year 42 €7,405 €7,755 +€350 +4.7%
Trade debts 44 €0 - =
Suppliers 440/4 €0 - =
Taxes, remuneration and social security 45 €5,803 €12,422 +€6,619 +114%
Taxes 450/3 €3,803 €10,420 +€6,617 +174%
Remuneration and social security 454/9 €2,000 €2,002 +€2 +0.1%
Other amounts payable 47/48 - €295 +€295
Accrued charges and deferred income 492/3 €913 €102 -€811 -88.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,127 €8,018 -€109 -1.3%
Other operating charges 640/8 €0 €453 +€453
Gross operating margin 9900 €36,337 €44,394 +€8,057 +22.2%
Operating profit (loss) 9901 €28,209 €35,923 +€7,714 +27.3%
Financial income 75/76B €3 €0 -€3 -100%
Recurring financial income 75 €3 €0 -€3 -100%
Financial charges 65/66B €1,294 €961 -€333 -25.8%
Recurring financial charges 65 €1,294 €961 -€333 -25.8%
Profit (loss) for the period before taxes 9903 €26,918 €34,962 +€8,044 +29.9%
Income taxes 67/77 €6,142 €7,841 +€1,698 +27.7%
Profit (loss) for the period 9904 €20,776 €27,122 +€6,346 +30.5%
Profit (loss) for the period to be appropriated 9905 €20,776 €27,122 +€6,346 +30.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€115,140 to €144,997

Midpoint €127,580 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €80,994
Capitalised earnings €149,286 to €209,000
Indication €115,140 to €144,997

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€80,994
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€80,994

Capitalised earnings

net result for the year (9904)
2025
€27,122
2024
€20,776
2023
€14,803
2022
€14,294
Average result
€20,900
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€149,286 / €174,167 / €209,000

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.